subsidiaries financial statement for 2nd quarter ended as of June 30, 2017, which details are as following; Results Q2/2017 Q2/2016 Increase (Decrease) Million Baht Million Baht Million Baht Percentage Total
its subsidiar ies financial statement for 3rd quarter ended as of September 30, 2017, which details are as following; Results Q3/2017 Q3/2016 Increase (Decrease) Million Baht Million Baht Million Baht
its subsidiaries financial statement for 3rd quarter ended as of September 30, 2017, which details are as following; Results Q3/2017 Q3/2016 Increase (Decrease) Million Baht Million Baht Million Baht
Discussion & Analysis (MD&A) Q4/2017 and FY2017 3 • Q4/2017 and FY2017 market environment Thailand’s Gross Domestic Product (GDP) has grew by 3.9% in 2017 which exceeds the 2016 by 0.7%, after recovering in
, did not achieve the target since the impact of the economic recession of the global markets, such as USA, Europe, China. In the meantime, the domestic market was affected from poor export economic
as it was necessary for customer-base expansion in dialysis solution segment to adjust selling price in order to be competitive with competitors in the same market. As a result, 2017 has gross margin
position for the first quarter ended March 31, 2019 with those of 2018. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai
million, a decrease of 41.6% comparing to Baht 1,369 million in 1Q19. The comprehensive income included revaluation of available-for-sale securities as a result of the capital market volatility. Operating
the increase in sales revenue, as well as the decrease in cost per unit from the increased production volume (Economy of scale). • Gross Profit margin in Q1/2024 was 66.5%, increased from 63.6% in Q1